Score Your Stock

US stock · figures in US dollars · scored on full-year results

Boston Scientific Boston Scientific Corporation Common Stock

BSX · Healthcare · Medical Devices
Top 15% of scored stocks
OkayTop 15% of scored stocks

Boston Scientific scores 68/100 on fundamentals: in the top 15% of 503 scored S&P 500 stocks. Its strongest area is Business Strength (90/100); its weakest is Cash & Dividends (50/100).

Best
Business 90
Weakest
Cash 50
Price 50

A stock with healthy growth, but cash & dividends needs attention.

What looks good
What to watch
Mkt capUS$ 60.7b#203 of 503 in the S&P 500EPSUS$ 2.37P/E17.4×✓ vs sector median 30.5×P/B2.4×✓ vs sector median 4×Div yieldNo dividends paidBottom 16% in the S&P 50052w range · 3% of range39.57105.65
as of 31 Oct 2026

Nearby peers

Ranks #6 of 60 in Healthcare by score

#1Universal Health Services79#4Dexcom73#5Insulet71
#6Boston Scientific68
#7Cooper Companies66#8Intuitive Surgical66

One-Minute Summary

Why Boston Scientific scores 68

A stock with healthy growth, but cash & dividends needs attention.

What looks good
What to watch

Business Strength

90
Why 90?
Pillar score: (1 + 2 + 2 + 2 + 2) = 9 of 10 points → 90
Return on Equity (ROE)14%Okay4-Year Revenue Growth+14%/yrStrong4-Year Profit Growth+30%/yrStrongNet Profit Margin17%StrongQuarterly Momentum+14%Strong
Show 3 charts

Net Profit & Equity, with ROE

Net Profit ↑ +119.8%Equity ↑ +29.3%ROE % 14%
Net ProfitEquityROE %
1.6b1.9b2.9b3.5b19.3b21.8b24.2b24.9b202320242025TTM8.3%8.5%12%14%

Revenue & Net Profit, with Net Margin

Revenue ↑ +48%Net Profit ↑ +119.8%Net Margin % 16.6%
RevenueNet ProfitNet Margin %
14.2b16.7b20.1b21.1b1.6b1.9b2.9b3.5b202320242025TTM11.2%11.1%14.4%16.6%

Sales grew about 48% over 4 years: customers keep spending more with this company.

Profit climbed about 119.8% over 4 years: the business keeps more money as it grows.

Recent Quarters: Revenue & Net Profit (the last 8 quarters, scored)

Revenue ↑ +29.3%Net Profit ↑ +93.8%Net Margin % 16.7%
RevenueNet ProfitNet Margin %
4.2b4.6b4.7b5.1b5.1b5.3b5.2b5.4b468m563m674m797m755m672m1.3b907mQ3'24Q4'24Q1'25Q2'25Q3'25Q4'25Q1'26Q2'2611.1%12.3%14.5%15.7%14.9%12.7%25.8%16.7%
▼▲▲▲▲▲▲▲

Sales grew about 29.3% over the last 8 quarters: customers keep spending more with this company.

Profit grew about 93.8% over the last 8 quarters: the business is keeping more of what it earns.

Why 67?
Pillar score: (1 + 1 + 2) = 4 of 6 points → 67
Debt-to-Equity0.5×OkayCurrent Ratio1.2×OkayInterest Coverage10.8×Strong
Show 2 charts

Debt vs Equity, with D/E ratio

Total Debt ↑ +33%Equity ↑ +29.3%D/E 0.5×
Total DebtEquityD/E
9.5b10.7b11.4b12.6b19.3b21.8b24.2b24.9b202320242025TTM0.5×0.5×0.5×0.5×

Borrowings grew about 33% over 4 years: watch this; rising debt adds pressure in bad times.

Short-term assets vs bills, with Current Ratio

Current Assets ↑ +22.4%Current Liabilities ↑ +30.3%Current Ratio 1.2×
Current AssetsCurrent LiabilitiesCurrent Ratio
6.5b6.9b8.8b8.0b4.9b6.4b5.4b6.4b202320242025TTM1.3×1.1×1.6×1.2×
Why 50?
Pillar score: (0 + 2 + 2 + 0) = 4 of 8 points → 50
Dividend QualityNo dividends paidWeak
Payout ratio: 0%
Operating Cash FlowPositive & growingStrongFree Cash FlowPositive & growingStrongCash & Cash EquivalentsShrinking & thinWeak
Show 3 charts

Operating vs Free Cash Flow

Operating CF ↑ +80.9%Free CF ↑ +6%
Operating CFFree CF
2.5b3.4b4.5b4.5b1.7b2.4b3.4b1.8b202320242025TTM

The business generates real cash, and more of it each year: a very healthy sign.

Cash vs Total Debt

Cash ↓ -37.7%Short-Term Debt ↑ +221.8%Total Debt ↑ +33%
CashShort-Term DebtTotal Debt
865m414m2.0b539m531m1.8b299m1.7b9.5b10.7b11.4b12.6b202320242025TTM

Dividends per Share, with Yield

DPS (cents) → +0%Yield % 0%
DPS (cents)Yield %
000020222023202420250%0%0%0%

Dividends per share have been maintained or raised: management shares the rewards with you.

Why 50?
Pillar score: (1 + 0 + 2) = 3 of 6 points → 50
P/E Ratio17.4×OkayP/B Ratio2.4×WeakPEG Ratio0.6Strong
Show chart

Share Price: Weekly Closes (not part of the score)

US$ 102.69US$ 72.33US$ 41.98Oct '25Feb '26Jun '26Oct '26

The share price is down about 58.3% over the past year.

Why 83?
Pillar score: (2 + 0 + 2 + 2 + 2 + 2) = 10 of 12 points → 83
Earnings ConsistencySteadyStrongDebt Trend (4yr)RisingWeakShare Count Trend (4yr)-0%/yrStrongInventory vs Sales (4yr)-4.7 pp/yr vs salesStrongAsset Turnover Trend (4yr)+15%StrongQuarterly Consistency0 of 4 quarters downStrong
Show chart

Revenue vs Inventory, with Inventory % of Revenue

Revenue ↑ +48%Inventory ↑ +30.2%Inv. % of Rev. 15.4%
RevenueInventoryInv. % of Rev.
14.2b16.7b20.1b21.1b2.5b2.8b2.9b3.2b202320242025TTM17.4%16.8%14.7%15.4%
Ranks #6 of 60 in Healthcare by score

Sector peers

#1Universal Health Services79#4Dexcom73#5Insulet71
#6Boston Scientific (you)68
#7Cooper Companies66#8Intuitive Surgical66

Full Financial History

Every reported figure behind the score, year by year. Download it, or check it against the company's own annual report.

Financial YearRevenueNet ProfitOperating Cash FlowFree Cash FlowCapExCashTotal DebtShort-Term DebtEquityCurrent AssetsCurrent LiabilitiesTotal AssetsTotal LiabilitiesInventoryDividendsReturn on Equity (ROE)Net Profit MarginDebt-to-EquityCurrent RatioInterest CoverageDividend Payout RatioDiv yieldP/E RatioP/B RatioPEG Ratio
2026US$ 21.1bUS$ 3.5bUS$ 4.5bUS$ 1.8bUS$ -2.7bUS$ 539.0mUS$ 12.6bUS$ 1.7bUS$ 24.9bUS$ 8.0bUS$ 6.4bUS$ 45.2bUS$ 20.0bUS$ 3.2b-14%17%0.5×1.2×10.8×-----
2025US$ 20.1bUS$ 2.9bUS$ 4.5bUS$ 3.4bUS$ -1.1bUS$ 2.0bUS$ 11.4bUS$ 299.0mUS$ 24.2bUS$ 8.8bUS$ 5.4bUS$ 43.7bUS$ 19.2bUS$ 2.9bUS$ 0.0m12%14%0.5×1.6×10.7×-0%48.5×5.8×0.8
2024US$ 16.7bUS$ 1.9bUS$ 3.4bUS$ 2.4bUS$ -1.1bUS$ 414.0mUS$ 10.7bUS$ 1.8bUS$ 21.8bUS$ 6.9bUS$ 6.4bUS$ 39.4bUS$ 17.4bUS$ 2.8bUS$ 0.0m9%11%0.5×1.1×8.5×0%0%72.1×6.1×3.4
2023US$ 14.2bUS$ 1.6bUS$ 2.5bUS$ 1.7bUS$ -800.0mUS$ 865.0mUS$ 9.5bUS$ 531.0mUS$ 19.3bUS$ 6.5bUS$ 4.9bUS$ 35.1bUS$ 15.6bUS$ 2.5bUS$ 0.0m8%11%0.5×1.3×8.5×2%0%53.2×4.4×-